Tag: Pfizer
Browse our exclusive articles!
Pfizer confirms COVID pill’s results, potency versus omicron
Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms.
Pfizer asks US officials to OK promising COVID-19 pill
Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.
FDA advisers back Pfizer’s COVID-19 vaccine for young kids
A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.
US close on deal with Pfizer for millions more vaccine doses
The U.S. government is close to a deal to acquire tens of millions of additional doses of Pfizer's vaccine in exchange for helping the pharmaceutical giant gain better access to manufacturing supplies.
VA to begin COVID-19 vaccinations at 128 additional sites
The Department of Veterans Affairs (VA) will begin COVID-19 vaccinations this week at 128 additional sites using the Moderna and Pfizer COVID-19 vaccines.
